Concepedia

Linda van der Merwe

LV

Statistics

Publications

11

Citations

1K

H-Index

10

Active since

2008

Affiliations

University of Cape Town(Current)

South African Tuberculosis Vaccine Initiative

University of Oxford

Jenner Institute

Netherlands Forensic Institute

Linda van der Merwe is an author at University of Cape Town specializing in infectious diseases, tuberculosis vaccination, and vaccinology.

Publications per year

2008–2021

11

Publications

11

The Novel Tuberculosis Vaccine, AERAS-402, Induces Robust and Polyfunctional CD4+ and CD8+ T Cells in Adults

Michèle Tameris, Nazma Mansoor, Sebastian Gelderbloem et al. · American Journal of Respiratory and Critical Care Medicine · 2010 · 227 citations

, , +17

Modified vaccinia Ankara‐expressing Ag85A, a novel tuberculosis vaccine, is safe in adolescents and children, and induces polyfunctional CD4<sup>+</sup> T cells

Thomas J. Scriba, Michèle Tameris, Nazma Mansoor et al. · European Journal of Immunology · 2009 · 190 citations · Full text

, , +17

Safety and Immunogenicity of a New Tuberculosis Vaccine, MVA85A, in Healthy Adults in South Africa

Tony Hawkridge, Thomas J. Scriba, Sebastian Gelderbloem et al. · The Journal of Infectious Diseases · 2008 · 170 citations · Full text

, , +17

Safety and immunogenicity of the adjunct therapeutic vaccine ID93 + GLA-SE in adults who have completed treatment for tuberculosis: a randomised, double-blind, placebo-controlled, phase 2a trial

Tracey A. Day, Adam Penn‐Nicholson, Angelique Kany Kany Luabeya et al. · The Lancet Respiratory Medicine · 2020 · 103 citations

, , +10

A Phase IIa Trial of the New Tuberculosis Vaccine, MVA85A, in HIV- and/or <i>Mycobacterium tuberculosis</i> –infected Adults

Thomas J. Scriba, Michèle Tameris, Erica Smit et al. · American Journal of Respiratory and Critical Care Medicine · 2012 · 86 citations · Full text

, , +17

1–5 of 11